Literature DB >> 22174098

Unilateral vitelliform maculopathy: a comprehensive phenotype study with molecular screening of BEST1 and PRPH2.

Mala Subash1, Tryfonas Rotsos, Genevieve A Wright, Sophie Devery, Graham E Holder, Anthony G Robson, Bishwanath Pal, Adnan Tufail, Andrew R Webster, Anthony T Moore, Michel Michaelides.   

Abstract

AIM: To describe the clinical features of a case series of patients with unilateral vitelliform maculopathy and the results of screening BEST1 and PRPH2 for disease-causing mutations. DESIGN/
METHODS: This was a retrospective case series study of six patients ascertained over a 2-year period. Ophthalmological examination, fundus photography, autofluorescence imaging, optical coherence tomography and detailed electrophysiological assessment were undertaken. Blood samples were taken for DNA extraction and mutation screening of BEST1 and PRPH2 was performed.
RESULTS: Six patients (3 men and 3 women) with unilateral vitelliform maculopathy were identified, ranging in age from 30 to 68 years. Vision in the affected eye ranged from 20/10 to 20/100. There was no clinical, retinal imaging or electrophysiological evidence of fellow eye involvement. Direct sequencing of BEST1 and PRPH2 did not reveal any disease-causing variants.
CONCLUSIONS: A case series of patients is reported with an unusual unilateral vitelliform phenotype, often associated with good visual function. The patients do not have the typical characteristics associated with age-related maculopathy or any inherited macular disorders, such as Best vitelliform macular dystrophy. Molecular screening of the candidate genes BEST1 and PRPH2 revealed no mutations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22174098     DOI: 10.1136/bjophthalmol-2011-300964

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  3 in total

1.  A 5-year-old girl with decreased vision in the left eye.

Authors:  Joel Yap; Dianne Sharp; Shuan Dai
Journal:  Digit J Ophthalmol       Date:  2015-05-09

2.  IMPG2-associated unilateral adult onset vitelliform macular dystrophy.

Authors:  Michalis Georgiou; Muhammad Z Chauhan; Michel Michaelides; Sami H Uwaydat
Journal:  Am J Ophthalmol Case Rep       Date:  2022-09-06

3.  Genetic variations in Bestrophin‑1 and associated clinical findings in two Chinese patients with juvenile‑onset and adult‑onset best vitelliform macular dystrophy.

Authors:  Ying Lin; Tao Li; Chenghong Ma; Hongbin Gao; Chuan Chen; Yi Zhu; Bingqian Liu; Yu Lian; Ying Huang; Haichun Li; Qingxiu Wu; Xiaoling Liang; Chenjin Jin; Xinhua Huang; Jianhua Ye; Lin Lu
Journal:  Mol Med Rep       Date:  2017-10-27       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.